Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.73 in the prior trading day, 4D Molecular Therapeutics Inc (NASDAQ: FDMT) closed at $9.17, up 5.04%. In other words, the price has increased by $5.04 from its previous closing price. On the day, 0.54 million shares were traded. FDMT stock price reached its highest trading level at $9.17 during the session, while it also had its lowest trading level at $8.655.
Ratios:
Our goal is to gain a better understanding of FDMT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.48 and its Current Ratio is at 28.48. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On April 15, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $459.
On April 15, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $45.Barclays initiated its Overweight rating on April 15, 2024, with a $45 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Bizily Scott sold 500 shares for $16.33 per share. The transaction valued at 8,165 led to the insider holds 6,781 shares of the business.
Bizily Scott sold 500 shares of FDMT for $7,500 on Aug 19 ’24. The Chief Legal Officer now owns 6,781 shares after completing the transaction at $15.00 per share. On Jul 16 ’24, another insider, Bizily Scott, who serves as the Chief Legal Officer of the company, sold 1,750 shares for $27.11 each. As a result, the insider received 47,442 and left with 6,781 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FDMT now has a Market Capitalization of 476561248 and an Enterprise Value of -51728860. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.67 while its Price-to-Book (P/B) ratio in mrq is 0.81. Its current Enterprise Value per Revenue stands at -2.559 whereas that against EBITDA is 0.408.
Stock Price History:
Over the past 52 weeks, FDMT has reached a high of $36.25, while it has fallen to a 52-week low of $8.53. The 50-Day Moving Average of the stock is -32.95%, while the 200-Day Moving Average is calculated to be -57.82%.
Shares Statistics:
The stock has traded on average 1.04M shares per day over the past 3-months and 1016000 shares per day over the last 10 days, according to various share statistics. A total of 51.97M shares are outstanding, with a floating share count of 43.74M. Insiders hold about 15.85% of the company’s shares, while institutions hold 105.44% stake in the company. Shares short for FDMT as of 1727654400 were 10925855 with a Short Ratio of 10.49, compared to 1724976000 on 9873630. Therefore, it implies a Short% of Shares Outstanding of 10925855 and a Short% of Float of 21.78.
